Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy
Kajal Gupta, Christina Nowicki, Eileena F. Giurini, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1497-1497
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Surface Mineralization of Engineered Bacterial Outer Membrane Vesicles to Enhance Tumor Photothermal/Immunotherapy
Xue Chen, Puze Li, Ban Luo, et al.
ACS Nano (2024) Vol. 18, Iss. 2, pp. 1357-1370
Closed Access | Times Cited: 34
Evaluation of a three-gene methylation model for correlating lymph node metastasis in postoperative early gastric cancer adjacent samples
Shang Chen, Shoubin Long, Yaru Liu, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 28
Mechanisms of Action and Limitations of Monoclonal Antibodies and Single Chain Fragment Variable (scFv) in the Treatment of Cancer
Cynthia Rodríguez-Nava, Carlos Ortuño‐Pineda, Berenice Illades‐Aguiar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1610-1610
Open Access | Times Cited: 32
Click-electrochemistry for the rapid labeling of virus, bacteria and cell surfaces
Sébastien Depienne, Mohammed Bouzelha, Emmanuelle Courtois, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Yaofeng Zhou, Qianying Li, Yuhao Wu, et al.
Advanced Materials (2024) Vol. 36, Iss. 21
Closed Access | Times Cited: 15
Surface Engineering on Bacteria for Tumor Immunotherapy: Strategies and Perspectives
Lijun Fu, Qing‐Yu He, Xiaoyang Lu, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 14
Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse
Yulin Zhang, Kaiyan Xi, Zhipeng Fu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Bacterial Systems as a Precision Delivery Platform of Therapeutic Peptides for Cancer Therapy
Jinyuan Liu, Guizhi Shen, Xuehai Yan
Polymer science & technology. (2025)
Open Access | Times Cited: 1
Genetically engineered bacteria-mediated multi-functional nanoparticles for synergistic tumor-targeting therapy
Yaotai Wang, Yu Tang, Yan Du, et al.
Acta Biomaterialia (2022) Vol. 150, pp. 337-352
Closed Access | Times Cited: 29
Recent advances in bacteria-mediated cancer therapy
Shuya Liang, Chao Wang, Yingchun Shao, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 29
Engineered bacteria for augmentedin situtumor vaccination
Xinyuan Shen, Chaojie Zhu, Xutao Liu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 4, pp. 1137-1152
Open Access | Times Cited: 21
Antioncogenic potential of probiotics: Challenges and future prospective
Sourav Chattaraj, Debasis Mitra, Abhishek Chattaraj, et al.
Indian Journal of Microbiology Research (2023) Vol. 10, Iss. 1, pp. 1-10
Open Access | Times Cited: 18
Insights into the enigma of oral streptococci in carcinogenesis
Sangeetha Senthil Kumar, Michael D. L. Johnson, Justin E. Wilson
Microbiology and Molecular Biology Reviews (2024) Vol. 88, Iss. 2
Closed Access | Times Cited: 7
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Ahmad Gholami, Milad Mohkam, Saeede Soleimanian, et al.
Microsystems & Nanoengineering (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies
Niloofar Kiaheyrati, Abouzar Babaei, Reza Ranji, et al.
Life Sciences (2024) Vol. 349, pp. 122734-122734
Closed Access | Times Cited: 5
In-situ synthesis of melanin in tumor with engineered probiotics for hyperbaric oxygen-synergized photothermal immunotherapy
Yi Xiao, Dongdong Wang, Ban Luo, et al.
Nano Today (2022) Vol. 47, pp. 101632-101632
Closed Access | Times Cited: 22
Cancer Vaccines in the Immunotherapy Era: Promise and Potential
Chaitenya Verma, Vishakha Anand Pawar, Shivani Srivastava, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1783-1783
Open Access | Times Cited: 13
Genetically engineered bacteria: a new frontier in targeted drug delivery
Saba Fooladi, Navid Rabiee, Siavash Iravani
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 42, pp. 10072-10087
Closed Access | Times Cited: 12
The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer
You Zhou, Yuqing Dong, Aixue Zhang, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 11
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy
Patricia Guevara-Ramí­rez, Santiago Cadena-Ullauri, Elius Paz‐Cruz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10255-10255
Open Access | Times Cited: 4
Leveraging Microorganisms to Combat Skin Cancer
Hayden J. Oyler, Austen W. Callister, Makenzi N. Kutch, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 462-462
Open Access
Immunotherapy in Advanced Prostate Cancer—Light at the End of the Tunnel?
Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2569-2569
Open Access | Times Cited: 18
Bifidobacterium in anticancer immunochemotherapy: friend or foe?
Giorgia Procaccianti, Sara Roggiani, Gabriele Conti, et al.
Microbiome Research Reports (2023) Vol. 2, Iss. 4
Open Access | Times Cited: 10
Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer
Zilong Zhu, Zhuze Chu, Fei Fei, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 64-64
Open Access
Page 1 - Next Page

Scroll to top